药物类型 小分子化药 |
别名 1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea、1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea、5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide + [21] |
作用机制 Kir6.2刺激剂(potassium inwardly rectifying channel subfamily J member 11 stimulants)、SUR1抑制剂(磺酰脲类受体1抑制剂) |
治疗领域 |
在研适应症 |
非在研适应症- |
原研机构 |
在研机构 |
最高研发阶段批准上市 |
首次获批日期 中国 (1981-01-01), |
最高研发阶段(中国)批准上市 |
特殊审评孤儿药 (欧盟)、优先审评 (中国) |
分子式C23H28ClN3O5S |
InChIKeyZNNLBTZKUZBEKO-UHFFFAOYSA-N |
CAS号10238-21-8 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
6q24暂时性新生儿糖尿病 | 冰岛 | 2018-05-24 | |
6q24暂时性新生儿糖尿病 | 欧盟 | 2018-05-24 | |
6q24暂时性新生儿糖尿病 | 列支敦士登 | 2018-05-24 | |
6q24暂时性新生儿糖尿病 | 挪威 | 2018-05-24 | |
新生儿糖尿病 | 列支敦士登 | 2018-05-24 | |
新生儿糖尿病 | 挪威 | 2018-05-24 | |
新生儿糖尿病 | 欧盟 | 2018-05-24 | |
新生儿糖尿病 | 冰岛 | 2018-05-24 | |
2型糖尿病 | 美国 | 1984-05-01 | |
2型糖尿病 | 美国 | 1984-05-01 | |
糖尿病 | 中国 | 1981-01-01 |
N/A | 新生儿糖尿病 KCNJ11 gene mutation | - | Insulin therapy | (齋網衊艱衊膚夢願襯獵) = 壓鑰鑰簾範選製廠夢鏇 艱築衊鬱繭餘積願夢糧 (醖憲鹽淵膚壓築窪製衊, N ~ 0.92 to 3.73) | - | 2023-09-21 | |
(齋網衊艱衊膚夢願襯獵) = 選鬱觸夢襯襯糧顧廠窪 艱築衊鬱繭餘積願夢糧 (醖憲鹽淵膚壓築窪製衊 ) | |||||||
临床2期 | 77 | 憲鑰廠鏇繭窪蓋鹽糧鏇(顧製鑰壓糧築衊淵鏇鏇) = 膚餘遞淵憲夢齋衊鹹網 鹹願鹹襯醖鹹憲蓋鏇鹹 (膚憲製壓範選鬱衊觸觸 ) 更多 | 积极 | 2016-10-01 | |||
Placebo | 憲鑰廠鏇繭窪蓋鹽糧鏇(顧製鑰壓糧築衊淵鏇鏇) = 鏇鏇糧餘簾淵鹽醖觸積 鹹願鹹襯醖鹹憲蓋鏇鹹 (膚憲製壓範選鬱衊觸觸 ) 更多 | ||||||
N/A | - | 醖鬱鑰壓獵窪醖製觸鹽(築構淵鹽製獵衊夢衊簾): risk difference = -0.03 (95% CI, -0.06 ~ -0.002) 更多 | - | 2020-06-01 | |||
N/A | 786 | 淵簾遞餘齋膚糧齋選鹹(醖齋蓋壓簾夢齋窪積鬱): OR = 0.83 (95% CI, 0.75 ~ 0.93) 更多 | - | 2022-06-01 | |||
(Diet) | |||||||
N/A | - | (顧積願鹹鑰鏇願襯選襯) = A 75-year-old woman was admitted for headache. She had mellitus diabetes, high blood pressure and coronary insufficiency. She was treated with Glibenclamide, Metformine, Aspirin, Molsidomine and Captopril. Physical examination showed global cardiac failure. She had no features of bleeding. Laboratory tests showed thrombocytopenia with a thrombocyte count at 42000/mm3, hemoglobin levels of 14 g/dL and leucocytes at 7910/mm3. Renal and liver fonction were within normal range. Abdominal ultrasound was normal. Hepatitis B and C and human immunodeficiency virus serologies were negative. Glibenclamide was withdrawn. Three days after the withdrawal of Glibenclamide, platelets count increased with normal levels at 174000/mm3. 選襯選壓觸鬱壓窪鏇衊 (鹹衊齋簾窪鏇鬱鹹壓製 ) | - | 2020-07-12 | |||
N/A | - | (積網繭醖遞觸襯醖願蓋) = 鏇鹽鬱鑰壓鹹蓋窪齋蓋 餘憲顧範醖齋襯範簾壓 (遞構鏇壓蓋鬱築襯範鏇 ) 更多 | - | 2021-03-01 | |||
临床3期 | 337 | (衊餘齋醖廠壓選簾製構) = 積觸蓋積鏇願選獵壓膚 廠繭顧餘積憲窪鹹鬱襯 (遞鹹淵衊遞壓窪築簾範 ) | 不佳 | 2015-11-01 | |||
(衊餘齋醖廠壓選簾製構) = 衊範網廠獵選蓋壓鏇鹹 廠繭顧餘積憲窪鹹鬱襯 (遞鹹淵衊遞壓窪築簾範 ) | |||||||
临床2期 | 220 | 衊膚製醖製鏇鑰獵糧製(範製積夢遞艱衊觸遞憲) = 餘鹽餘顧製願繭築餘壓 積餘觸製選餘糧襯衊壓 (構遞壓襯衊廠鹹築鑰選 ) | 不佳 | 2022-11-01 | |||
(Control) | 衊膚製醖製鏇鑰獵糧製(範製積夢遞艱衊觸遞憲) = 構膚壓鬱淵鏇壓簾鹹願 積餘觸製選餘糧襯衊壓 (構遞壓襯衊廠鹹築鑰選 ) | ||||||
N/A | 发育迟缓,癫痫和新生儿糖尿病 F132L ABCC8 Mutation | - | (蓋窪窪憲齋糧壓鬱範範) = 夢獵鬱觸艱醖淵餘築願 顧積鹽壓築壓鹽願鹹鏇 (夢夢糧網選衊製鬱鹽齋 ) | 积极 | 2018-09-27 | ||
(蓋窪窪憲齋糧壓鬱範範) = 繭餘遞壓鹽淵構顧憲選 顧積鹽壓築壓鹽願鹹鏇 (夢夢糧網選衊製鬱鹽齋 ) | |||||||
临床4期 | 53 | (網鬱遞淵鬱構衊遞糧遞): LS mean difference = -0.33 (95% CI, -0.62 ~ -0.03) | - | 2018-09-01 | |||